Events

Buhlmann – Next Generation Food Allergy Drug Development Summit

Next Generation Food Allergy Drug Development Summit, July 20-22, 2021: BUHLMANN is proud to partner with this event, specifically focused ...
Read More

Digestive Disease Week 2021

Assays Offerings We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including ...
Read More

Visit BUHLMANN at AACC 2021 (LIVE)

Assays Offerings We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United States, including ...
Read More

Educational Webinar recording from AMLI presentation by Dr Arne Roseth

BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use. Health Canada License: 80726 Abstract Inflammatory Bowel Disease (IBD) is a ...
Read More